Publication | Closed Access
50 BOCEPREVIR PLUS PEGINTERFERON/RIBAVIRIN FOR THE TREATMENT OF HCV/HIV CO-INFECTED PATIENTS: END OF TREATMENT (WEEK 48) INTERIM RESULTS
27
Citations
0
References
2012
Year
Viral HepatitisWeek 48Antiviral Drug DevelopmentAntiviral TherapyHepatitisVirologyInterim ResultsPharmacotherapyChronic Viral InfectionAntiviral DrugHivMedicineBoceprevir Plus Peginterferon/ribavirin
No additional data available for this publication yet. Check back later!